Mandate

Vinge advises Ambea on its acquisition of Aleris Care

October 16, 2018 Banking and Finance

Vinge has advised Ambea on its acquisition of Aleris’ care operations (“Aleris Care”) from Sirela Sweden AB, which is indirectly owned by Investor through Patricia Industries.

The purchase price amounted to SEK 2.6 billion on a debt free case free basis. Aleris Care is the leader in the private market for care services in Norway, the sixth largest private operator in Sweden and the largest private provider in the Denmark. Today, Ambea is the second largest player in the private market for care services in Sweden and the seventh largest in Norway. Following the acquisition, Ambea will be the largest care provider in the Nordic region with operations in Sweden, Norway and Denmark. The transaction is subject to regulatory approval by the relevant competition authorities and closing is expected to occur during the first quarter of 2019.
 
Vinge’s team consisted of partners Christina Kokko (M&A), Charlotte Levin (Public M&A and Capital Markets), Albert Wållgren (Banking and Finance) and Johan Karlsson (Competition) together with associates Johanna Wiberg, Martin Cronsioe and Karolina Cohrs (M&A), Linn Adelwald, Josefine Lanker and Josefine Larsson (Banking and Finance), Nicklas Thorgerzon, Fredrika Hjelmberg, Hayaat Ibrahim and Victor Berg (Commercial Agreements), Klara Secher (IP), Kristoffer Larson (Real Estate), Sara Strandberg and Lisa Ullman (Employment), Trine Osen Bergqvist, Xandra Ståhlberg and Sofia Landolsi (Competition), Hannes Pettersson (Corporate), Maria Schultzberg, Victor Ericsson and Henrik Wastenson (Tax) and VDR assistant Jessica Öijer. 

Selmer (Norway) and Accura (Denmark) has advised on the transaction’s Norwegian and Danish legal and tax aspects. 
 

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026